Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun:75:105-109.
doi: 10.1016/j.parkreldis.2020.05.011. Epub 2020 May 8.

Machine learning-assisted neurotoxicity prediction in human midbrain organoids

Affiliations
Free article

Machine learning-assisted neurotoxicity prediction in human midbrain organoids

Anna S Monzel et al. Parkinsonism Relat Disord. 2020 Jun.
Free article

Abstract

Introduction: Brain organoids are highly complex multi-cellular tissue proxies, which have recently risen as novel tools to study neurodegenerative diseases such as Parkinson's disease (PD). However, with increasing complexity of the system, usage of quantitative tools becomes challenging.

Objectives: The primary objective of this study was to develop a neurotoxin-induced PD organoid model and to assess the neurotoxic effect on dopaminergic neurons using microscopy-based phenotyping in a high-content fashion.

Methods: We describe a pipeline for a machine learning-based analytical method, allowing for detailed image-based cell profiling and toxicity prediction in brain organoids treated with the neurotoxic compound 6-hydroxydopamine (6-OHDA).

Results: We quantified features such as dopaminergic neuron count and neuronal complexity and built a machine learning classifier with the data to optimize data processing strategies and to discriminate between different treatment conditions. We validated the approach with high content imaging data from PD patient derived midbrain organoids.

Conclusions: The here described model is a valuable tool for advanced in vitro PD modeling and to test putative neurotoxic compounds.

Keywords: Machine learning; Midbrain organoids; Neurotoxicity; Parkinson's disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest JCS is co-founder and CEO of the biotech company OrganoTherapeutics which uses the here described model for drug development. RK is member of the advisory board of the same company. Apart from that the authors declare no conflict of interest.

Publication types

MeSH terms

LinkOut - more resources